Get the Stockscreener App
9.89
0.10%
-0.010
After Hours:
9.89
Bluerock Acquisition Corp stock is traded at $9.89, with a volume of 14,034.
It is down -0.10% in the last 24 hours and up +0.00% over the past month.
Bluerock Acquisition Corp is a blank check company incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
See More
Previous Close:
$9.90
Open:
$9.92
24h Volume:
14,034
Relative Volume:
26.89
Market Cap:
$227.47M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.10%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$9.89
$9.92
1-Week Range:
$9.89
$9.95
52-Week Range:
$9.87
$9.95
Bluerock Acquisition Corp Stock (BLRK) Company Profile
Name
Bluerock Acquisition Corp
Sector
Industry
Phone
212-843-1601
Address
27777 FRANKLIN ROAD, SUITE 900, SOUTHFIELD
Compare BLRK vs CCXI, LION, XXI, CCCX, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLRK
Bluerock Acquisition Corp
|
9.89 | 227.70M | 0 | 0 | 0 | 0.00 |
|
CCXI
Churchill Capital Corp Xi
|
10.24 | 3.64B | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.97 | 2.63B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
XXI
Twenty One Capital Inc
|
5.80 | 2.10B | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
13.21 | 746.92M | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.99 | 655.09M | 0 | 0 | 0 | 0.00 |
Bluerock Acquisition Corp Stock (BLRK) Latest News
Does Bluerock Homes Trust Inc. meet Warren Buffett’s criteriaMarket Rally & Technical Analysis for Trade Confirmation - mfd.ru
Market Today: Palantir beats, Disney warns; oil slides - GuruFocus
Cost of Blue Rock Springs golf course retooling increase by $4 million - MSN
Bluerock Acquisition Corp Announces Separate Trading of Shares and Warrants - TradingView
Bluerock Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about February 2, 2026 - PR Newswire
Amazon cuts about 16,000 corporate jobs in the latest round of layoffs - WFMZ.com
Top Analyst Reports for NextEra Energy, Newmont & Blackstone - TradingView
Bluerock Acquisition Corp. Appoints Ziv Conen to the Board to Serve as a Class II Director - marketscreener.com
Paramount extends its deadline for its Warner Bros. tender offer, again - WFMZ.com
Bluerock Homes Trust Expands Portfolio with Georgia Acquisition - TipRanks
Perkins Coie Advises Bluerock Acquisition Corp. on $172.5M IPO - Perkins Coie
U.S. IPO Weekly Recap: Wealthfront Leads 4 IPO Week, While United Rentals Challenger Submits Filings - Seeking Alpha
Bluerock Infrastructure Solutions Discloses Share Sale in Zodiac-JRD-MKJ Limited Under SEBI Regulations - scanx.trade
Bluerock Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering - PR Newswire
IPO NewsUS IPO Weekly Recap: Beta Technologies leads 6 deal week to open November - renaissancecapital.com
Vallejo council approves Blue Rock Springs Golf Course redesign plans - Times Herald Online
Jennifer Terrell | Fairness and Solvency Opinions | Kroll Chicago - Kroll
Looking to early-stage companies for innovation, with Juergen Eckhardt - pharmaphorum
US NYSE/NASD Stock Directory - Minichart
Winning strategies: Bayer bares all on ‘arm’s length’ acquisitions - BioXconomy
Bayer to acquire TPG-backed Asklepios Bio worth up to $4 billion - Private Equity Insights
Bluerock Capital Markets Hires Jeffrey Klepacki as Executive Vice President - citybiz
Aon Selling Townsend Group to US PE Firm Riverside as Property Strategies Struggle - Mingtiandi
Investor group led by Riverside to acquire The Townsend Group from Aon - GlobeNewswire
Ophir hops onto BlueRock’s register; expands into unlisted markets - AFR
Professional services biz BlueRock seeks growth capital partner - AFR
[KBR Exclusive: Inside Boston Biocluster] Bayer spearheads cell and gene therapy advancement, shaping healthcare’s future - koreabiomed.com
Bayer’s bet on CGT: Casting a wide net for innovation - pharmaphorum
BLUEROCK RESIDENTIAL GROWTH REIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com
Bluerock Residential Growth REIT and Blackstone Real Estate Announce Anticipated Closing Date of Acquisition and Spin-Off - citybiz
Intact acquires Blue Rock Systems to accelerate UK growth - Techzine Global
Intact Software Acquires UK Reseller Blue Rock Systems - businessplus.ie
‘Multi-million pound’ deal sees Intact software acquire UK’s Blue Rock Systems - The Irish Independent
Blackstone Buys Preferred Apartment Communities for $5.8B in Latest Strategic Move - Multifamily Housing News
Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform - Fierce Pharma
Blackstone to Buy Bluerock Residential Growth in $3.6B Deal - Multifamily Housing News
Bluerock Residential Growth REIT To Be Acquired By Affiliates of Blackstone Real Estate In $3.6 Billion Transaction - PR Newswire
BlueRock, BGO buy real estate in Berlin for over €200m - IPE Real Assets
Central African Gold Refutes Claims by Bluerock - TMX Newsfile
Bayer acquires AskBio to broaden innovation base in cell and gene therapy - Healthcare Radius
BlueRock Diamonds PLC announce sale of 3,805 carats for an aggregate consideration of US$1,255,000 - Proactive financial news
Appliance store in Lehigh Valley closing after 84 years in business - WFMZ.com
BlueRock Therapeutics remains committed to Toronto following $1 billion USD acquisition - BetaKit
Bluerock Real Estate buys Links at Plum Creek apartments - Colorado Real Estate Journal
Phillipsburg to present its Riverfront Redevelopment Plan - WFMZ.com
Curis Emerges from Three Boston Biotech Companies - Pharmaceutical Online
Blue Rock Premier Properties Lands 3rd FL Community - Multifamily Housing News
Bluerock Residential Announces Acquisition of Park & Kingston Apartments in Charlotte, NC - MultifamilyBiz
Upper East Side Penthouse for $37.94 Million (Published 2015) - The New York Times
Bluerock Acquisition Corp Stock (BLRK) Financials Data
There is no financial data for Bluerock Acquisition Corp (BLRK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.49%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):